Home/Protocols/Pigmentation & Melasma/MLX.cr
Pigmentation & Melasmaprodermic MLX.cr

Melasma Corrective for Melasma & PIH

Melasma Corrective
SKU MEL · 50ml · Treatment Cream
1,498
MRP 2,995
~10 sessions per jar · 150/session
50% Professional Margin
Per-Session Economics
What do you charge per session?3,500
1,00010,000
Your cost per session150
Your profit per session3,350
~10Sessions/jar
35,000Revenue/jar
33,500Profit/jar

Prodermic MLX.cr is a 7-agent multi-pathway depigmentation cream for inter-session melasma maintenance.The ATK-7M Complex combines Alpha-Arbutin for competitive tyrosinase inhibition, Tranexamic Acid for plasmin-mediated melanocyte suppression, Kojic Acid Dipalmitate for stable copper chelation, Niacinamide for melanosome transfer inhibition, and Bakuchiol for retinol-like renewal without irritation.The go-to melasma maintenance take-home for every pigmentation patient.

Indications
Melasma
Melasma
PIH Maintenance
PIH Maintenance
Hyperpigmentation
Hyperpigmentation
Active Agents
Hyaluronic Acid
Niacinamide
Alpha-Arbutin
Tranexamic Acid
Panthenol
Kojic Acid Dipalmitate
Ceramide NP
Bakuchiol
Volume
50ml
Sessions/Jar
~10
Peel Depth
Superficial
Fitzpatrick
Professional use
Category
Cream
Shelf Life
24 months
Dispatch
Same Day
Min Order
1 unit
Same-Day Dispatch
Zero Minimum
GMP Certified
Prodermic Certified
Prodermic® Certified Seller
Only purchase Prodermic® products from certified partners and authorized distributors to ensure genuine formulations.
Complete Protocol Stack
Recommended clinical workflow for prodermic MLX.cr
01
prodermic PREP.01
Pre-Protocol
₹348
02
prodermic MLX.cr
Melasma Corrective
₹1,498
03
prodermic NEUT.01
Neutralizer
₹448
04
prodermic REST.01
Recovery Balm
₹1,500
Total Stack3,794
Order Complete Stack
Formulation Technology

Arbutin-Tranexamic Correction™

ATK-7MComplex

ATK-7M Complex — 7-agent arbutin-tranexamic-kojic depigmentation maintenance cream with bakuchiol.

Application Protocol

Recommended sequence for prodermic MLX.cr. Frequency: As prescribed.

Step 01
Apply as directed by physician
Mechanism of Action
Alpha-Arbutin
Competitive tyrosinase inhibition for pigment suppression.
Tranexamic Acid
Plasmin inhibition reducing UV-induced melanocyte activation.
Kojic Acid Dipalmitate
Stable copper chelation at tyrosinase active site.
Niacinamide
Melanosome transfer inhibition reducing pigment delivery.
Bakuchiol
Retinol-like epidermal turnover without photosensitization.
Alpha-Arbutin + Tranexamic Acid
Lead Active
Multi-agent
Total Concentration
N/A (topical)
Peel Depth
None
Aggression
Ideal Patient Profile

All melasma and PIH patients needing inter-session maintenance cream.

Clinical Note

If desired results are not achieved, it does not indicate the peel is ineffective—it may simply mean that the skin has a higher tolerance to the current formulation. In such cases, consider transitioning to a stronger peel, applying multiple coats, or increasing the application time in subsequent sessions.